Mallinckrodt Pharmaceuticals (MNK) stock price, revenue, and financials

Mallinckrodt Pharmaceuticals market cap is $115.9 m, and annual revenue was £90.37 m in FY 2018

$115.9 M

MNK Mkt cap, 18-Sept-2020

£90.4 M

Mallinckrodt Pharmaceuticals Revenue FY, 2018
Mallinckrodt Pharmaceuticals Gross profit (FY, 2018)8.4 M
Mallinckrodt Pharmaceuticals Gross profit margin (FY, 2018), %9.3%
Mallinckrodt Pharmaceuticals Net income (FY, 2018)3.9 M
Mallinckrodt Pharmaceuticals EBITDA (FY, 2018)3.5 M
Mallinckrodt Pharmaceuticals EBIT (FY, 2018)3.5 M

Mallinckrodt Pharmaceuticals Revenue

Mallinckrodt Pharmaceuticals revenue was £90.37 m in FY, 2018

Embed Graph

Mallinckrodt Pharmaceuticals Income Statement

Annual

GBPFY, 1995FY, 1996FY, 1997FY, 1998FY, 1999FY, 2000FY, 2001FY, 2002FY, 2003FY, 2004FY, 2005FY, 2006FY, 2007FY, 2008FY, 2009FY, 2010FY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Revenue

20.8m22.0m25.5m26.3m26.7m23.9m28.4m27.8m30.7m28.9m34.3m38.0m36.6m45.4m71.6m65.9m72.6m79.6m89.7m62.6m64.2m65.0m108.0m90.4m

Revenue growth, %

(30%)3%

Cost of goods sold

16.2m16.1m19.7m21.5m19.7m19.9m23.6m22.0m23.8m22.5m27.7m31.6m31.5m36.3m56.0m56.4m65.0m70.6m79.8m56.3m55.4m56.5m99.4m82.0m

Gross profit

4.6m5.9m5.8m4.8m6.9m4.0m4.7m5.8m6.9m6.4m6.6m6.5m5.1m9.0m15.6m9.5m7.6m9.0m9.9m6.3m8.8m8.5m8.6m8.4m

Gross profit Margin, %

22%27%23%18%26%17%17%21%22%22%19%17%14%20%22%14%10%11%11%10%14%13%8%9%

Operating expense total

4.0m4.0m4.3m4.6m4.6m4.6m5.1m4.1m3.6m3.6m3.8m4.4m3.9m6.1m7.5m5.2m6.1m5.5m5.8m3.8m6.8m6.6m4.0m4.9m

EBITDA

2.0m3.7m8.9m5.1m2.2m4.1m2.5m1.9m1.9m4.7m3.5m

EBITDA margin, %

6%8%12%8%3%5%4%3%3%4%4%

EBIT

626.0k1.8m1.5m196.0k2.3m(599.0k)(339.0k)1.8m3.3m2.8m2.8m2.1m1.1m3.0m8.1m4.3m1.4m3.5m4.1m2.5m1.9m1.8m4.7m3.5m

EBIT margin, %

3%8%6%1%9%(3%)(1%)6%11%10%8%5%3%7%11%7%2%4%5%4%3%3%4%4%

Pre tax profit

81.0k1.7m1.1m133.0k2.3m(515.0k)(2.6m)1.8m3.4m3.1m3.4m2.6m1.8m3.8m8.3m4.3m(7.9m)2.8m3.8m2.4m2.0m1.7m4.6m3.9m

Income tax expense

(101.0k)(675.0k)(471.0k)(146.0k)(760.0k)31.0k35.0k(552.0k)754.0k606.0k255.0k(599.0k)(567.0k)(1.1m)(2.4m)(368.0k)4.0k458.0k(748.0k)(528.0k)(117.0k)(171.1k)1.6k(800.0)

Net Income

(20.0k)1.0m648.0k(13.0k)1.5m(484.0k)(2.5m)1.3m4.1m3.7m3.6m2.0m1.2m2.7m5.9m3.9m(7.9m)3.3m3.0m1.9m1.9m1.5m4.6m3.9m

Mallinckrodt Pharmaceuticals Balance Sheet

Annual

GBPFY, 1995FY, 1996FY, 1997FY, 1998FY, 1999FY, 2000FY, 2001FY, 2002FY, 2003FY, 2004FY, 2005FY, 2006FY, 2007FY, 2008FY, 2009FY, 2010FY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Cash

938.0k315.0k713.0k591.0k155.0k227.0k187.0k548.0k132.0k2.4m3.0k710.0k1.0k1.0k9.6m1.4m403.0k

Accounts Receivable

3.9m4.2m4.4m3.9m4.3m5.0m4.3m5.3m4.6m5.4m5.8m5.8m7.2m8.3m10.2m11.0m11.4m12.7m11.1m13.4m12.4m12.9m19.5m15.6m

Inventories

3.0m4.2m3.5m3.5m4.0m3.2m3.9m4.4m3.6m2.7m2.0m4.0m4.9m6.4m10.0m11.4m12.3m10.8m6.1m4.9m7.0m7.6m7.1m5.3m

Current Assets

8.9m9.4m12.5m10.0m11.4m10.2m10.7m13.7m17.6m22.0m24.4m26.2m29.3m31.5m51.1m45.2m50.5m42.8m43.0m50.1m53.5m58.3m76.6m29.9m

PP&E

8.0m7.9m7.8m7.3m7.1m7.0m6.4m5.8m5.3m5.3m5.7m6.7m6.6m6.7m6.3m6.4m1.8m1.0m87.0k64.0k44.0k31.2k9.6k4.0k

Total Assets

20.5m20.7m23.5m20.1m21.2m19.6m17.1m19.6m22.9m27.3m30.1m33.0m35.9m38.2m57.5m51.6m52.2m43.9m43.1m50.2m53.5m58.4m76.6m29.9m

Accounts Payable

1.2m1.2m1.3m1.1m863.0k790.0k966.0k1.0m918.0k1.8m1.6m1.3m1.6m1.0m1.9m414.0k1.0m283.0k70.0k67.0k60.0k74.4k82.4k172.8k

Current Liabilities

6.9m5.7m7.5m4.1m3.6m2.5m2.7m3.9m3.3m4.6m4.0m4.7m6.3m6.0m19.4m9.9m13.4m5.9m4.4m9.7m9.7m7.0m16.8m6.9m

Non-Current Liabilities

330.0k664.0k1.1m1.1m1.1m1.0m976.0k909.0k805.0k199.0k1.1m341.0k770.0k1.9m1.5m6.5m2.3m81.0k

Total Debt

326.0k755.0k1.0m268.0k484.0k252.0k23.0k5.2k22.4k5.6k

Total Liabilities

7.2m6.4m8.5m5.2m4.7m3.6m3.6m4.8m4.1m4.8m4.0m5.8m6.7m6.8m21.3m11.4m19.9m8.3m4.5m9.7m9.7m7.0m16.8m6.9m

Common Stock

11.9m11.9m11.9m11.9m11.9m11.9m11.9m11.9m11.9m11.9m11.9m11.9m11.9m11.9m11.9m11.9m11.9m11.9m11.9m11.9m11.9m14.6m15.7m15.7m

Retained Earnings

22.7m24.6m26.4m34.9m42.1m5.2m

Total Equity

13.3m14.3m15.0m15.0m16.5m16.0m13.5m14.8m18.9m22.5m26.1m27.2m29.2m31.4m36.2m40.3m32.4m35.6m38.6m40.5m43.9m51.4m59.8m22.9m

Debt to Equity Ratio

0 x0 x0 x0 x0 x0 x0 x0 x0 x0 x

Debt to Assets Ratio

0 x0 x0 x0 x0 x0 x0 x0 x0 x0 x

Financial Leverage

1.5 x1.4 x1.6 x1.3 x1.3 x1.2 x1.3 x1.3 x1.2 x1.2 x1.2 x1.2 x1.2 x1.2 x1.6 x1.3 x1.6 x1.2 x1.1 x1.2 x1.2 x1.1 x1.3 x1.3 x

Mallinckrodt Pharmaceuticals Cash Flow

Annual

GBPFY, 1995FY, 1996FY, 1997FY, 1998FY, 1999FY, 2000FY, 2001FY, 2002FY, 2003FY, 2004FY, 2005FY, 2006FY, 2007FY, 2008FY, 2009FY, 2010FY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Net Income

(20.0k)1.0m648.0k(13.0k)1.5m(484.0k)(2.5m)1.3m4.1m3.7m3.6m2.0m1.2m2.7m5.9m3.9m(7.9m)3.3m3.0m1.9m1.9m1.5m4.6m3.9m

Dividends Paid

40.8m

Income Taxes Paid

(748.0k)(528.0k)(117.0k)

Mallinckrodt Pharmaceuticals Ratios

GBPFY, 1995

Financial Leverage

1.5 x

Mallinckrodt Pharmaceuticals Employee Rating

2.9343 votes
Culture & Values
3
Work/Life Balance
3
Senior Management
2.3
Salary & Benefits
3.3
Career Opportunities
2.8
Source